Trial Details
UNKNOWNBasic Information
| Clinical ID | c1244 |
|---|---|
| Identifier | NCT01216280 |
| Trial Title | Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: placebo capsule|DRUG: 10 mg Natura-alpha capsule and 10 mg placebo capsule|DRUG: 2 x 10 mg Natura-alpha capsules |
Participant Information
| Sponsor | Natrogen Therapeutics International, Inc |
|---|---|
| City | Anaheim |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-07-10 |
|---|---|
| Primary Completion Date | 2025-07-11 |
| Completion Date | 2025-09-11 |